SCHEMBL29502491

SCHEMBL29502491

Cc1cc2c([nH]c3ccc(O)cc32)c2c1OC(C)(C)C=C2

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.72
▸ POLB P06746 2/20 0.72
▸ XBP1 P17861 2/20 0.72
▸ NPC1 O15118 1/20 0.72
▸ RAB9A P51151 1/20 0.72
▸ KMT2A Q03164 4/20 0.55
▸ GAA P10253 2/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ IDE P14735 1/20 0.55
▸ MEN1 O00255 3/20 0.49
▸ PNLIP P16233 1/20 0.49
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Grinimibine SCHEMBL4132680 0.84 MAPT (1.00) MAPTPOLBXBP1NPC1RAB9A
Koenimbine SCHEMBL29581663 0.83 MAPT (0.69) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL29814874 0.81 MAPT (0.62) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL31324179 0.79 MAPT (0.60) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL30929796 0.78 MAPT (0.65) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL30929792 0.76 MAPT (0.69) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL13344164 0.71 MAPT (1.00) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL13142229 0.71 MAPT (1.00) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL18317471 0.71 MAPT (1.00) MAPTPOLBXBP1NPC1RAB9A
SCHEMBL31324206 0.70 MAPT (0.57) MAPTPOLBXBP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4647073-A1 MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS Nutraceutical Technology Pharma Biotech S.r.l. (IT) 2025-11-12 — — EP claimed
WO-2025018822-A1 RECOMBINANT ADENO-ASSOCIATED VIRUS FOR PREVENTING OR TREATING LAFORA DISEASE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 제닉스큐어 주식회사 2025-01-23 — — WO claimed
CN-122094681-A Carbazole compounds and therapeutic use thereof in the treatment of respiratory infections — 2026-05-26 — — CN disclosed
EP-4743082-A1 CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION UCL Business Ltd (GB) 2026-05-20 — — EP disclosed
EP-4647073-A1 MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS Nutraceutical Technology Pharma Biotech S.r.l. (IT) 2025-11-12 — — EP disclosed
WO-2025018822-A1 RECOMBINANT ADENO-ASSOCIATED VIRUS FOR PREVENTING OR TREATING LAFORA DISEASE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 제닉스큐어 주식회사 2025-01-23 — — WO disclosed
WO-2025012634-A1 CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION UCL BUSINESS LTD (GB) 2025-01-16 — — WO disclosed
WO-2022060155-A1 GENE THERAPY VECTOR WITH MINIMIZED RECOMBINATION OCCURRENCE, RECOMBINANT RETROVIRUS COMPRISING VECTOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING RECOMBINANT RETROVIRUS (주)알티큐어 2022-03-24 — — WO disclosed
Send feedback